Free adult chat line 47 local numbers
Kliff and Vox for responding to me; it’s always neat to get featured in real news sources as if I were a real writer or something instead of just a guy with a blog.
Additional thanks for a very measured and charitable tone despite my own tendency toward snarkiness.
Brand-name drugs are overpriced because of a deliberate decision to overprice them to encourage research.
The economic argument goes: the more profitable new drugs are, the more incentive a company has to make them.
[…] Alexander and I are both essentially pointing out two examples of how the United States has created a regulatory system that is incredibly favorable to pharmaceutical companies.
If we didn’t reward pharmaceutical companies for inventing new drugs, then they wouldn’t go through the .5 billion, ten-year hassle of seeking FDA approval with no guarantee of success.
The way we reward them is by giving them a twenty-year monopoly when they can charge lots of money without anybody telling them not to. The law says a twenty-year monopoly, but it’s dated from the time the drug is invented.
I would kind of like to complain about Vox calling Epi Pen a “red herring” when they were the ones who brought it up, but I think the problem is deeper than that.
Discussing generic drug costs is completely different from discussing brand name drug costs, and the two issues have very different arguments around them.
Search for Free adult chat line 47 local numbers:
I didn’t want to wade into this complicated debate. The results can be interpreted as further evidence of the deteriorating effect of regulation on firm’s incentives to invest in R&D.” 3.